PACS GROUP INC. O.N. Aktie

PACS Group’s stock climbed to an all-time high of $47.35, bringing market capitalization to $7.09 billion. Over the past year the stock is up 297.78%, but InvestingPro currently rates it as overvalued. For Q1 2026 the company reported EPS of $0.50 (expectation $0.44) and revenue of $1.42 billion (+11% y/y). PACS announced the acquisition of 34 care facilities (3,633 beds), Truist reiterated its buy rating, and options trading showed increased call activity. » More on de.investing.com

PACS Group shares rose to a new all-time high of $45.89, recording a yearly performance of 270.43%. The company has a market capitalization of $7.1 billion, revenue growth of 22% over the past twelve months and an EPS of $1.56. PACS beat Q1 2026 expectations with an EPS of $0.50 (forecast $0.44) on revenue of $1.42 billion and announced the acquisition of 34 care facilities with 3,633 beds. Truist reiterated its buy rating with a $52.00 price target, while InvestingPro classifies the stock as overvalued and reports a Piotroski score of 9. » More on de.investing.com

Pacs Group options trading volume rose to 7,248 contracts by 1:50 p.m. New York time, of which 7,245 were calls and only 3 were puts. The largest position was 7,133 calls with a $50 strike expiring January 15, 2027; the open interest for that contract was 2,735 contracts as of July 1. The stock climbed 0.81% to $44.68; three-month volatility fell to 66.45%, while the three-month skew (90/110) rose to 3.40 percentage points. » More on de.investing.com